Management of Infected Galactocele and Breast Implant with Uninterrupted Breastfeeding

Summary:. Infected breast implants during lactation present a rare but challenging clinical scenario that may result in early cessation of breastfeeding and unnecessary morbidity to mother and infant. We present the case of a 39-year-old African American primigravid woman with a history of bilateral...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hannah Kornfeld, MD, Arianne Johnson, PhD, Marc Soares, MD, FACS, Katrina Mitchell, MD, FACS, IBCLC
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Acceso en línea:https://doaj.org/article/289e70e85be34f97b4f0f9f5979d1963
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:289e70e85be34f97b4f0f9f5979d1963
record_format dspace
spelling oai:doaj.org-article:289e70e85be34f97b4f0f9f5979d19632021-11-25T07:58:04ZManagement of Infected Galactocele and Breast Implant with Uninterrupted Breastfeeding2169-757410.1097/GOX.0000000000003943https://doaj.org/article/289e70e85be34f97b4f0f9f5979d19632021-11-01T00:00:00Zhttp://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003943https://doaj.org/toc/2169-7574Summary:. Infected breast implants during lactation present a rare but challenging clinical scenario that may result in early cessation of breastfeeding and unnecessary morbidity to mother and infant. We present the case of a 39-year-old African American primigravid woman with a history of bilateral retropectoral textured implants placed three years prior. Five days after delivering a healthy, full-term infant via cesarean section, she sought evaluation for nipple pain and trauma. She was instructed to use a nipple shield and pump every 2–3 hours in addition to breastfeeding, which resulted in iatrogenic hyperlactation. One week postpartum, the patient was started on antibiotics for presumed mastitis. Ultrasound demonstrated a complex fluid collection at the 12 o’clock periareolar position, as well as peri-implant fluid. She subsequently underwent aspirations of a periareolar complex galactocele and aspirations of peri-implant fluid. She continued on antibiotics without improvement. The patient proceeded to implant removal and definitive drainage of the galactocele at four months postpartum. Throughout her course, the patient provided her infant with exclusive breastmilk, including breastfeeding in the perioperative area of the operating room. This case demonstrates an example of safe surgical removal of infected breast implants and management of an infected galactocele without interruption of breastfeeding.Hannah Kornfeld, MDArianne Johnson, PhDMarc Soares, MD, FACSKatrina Mitchell, MD, FACS, IBCLCWolters KluwerarticleSurgeryRD1-811ENPlastic and Reconstructive Surgery, Global Open, Vol 9, Iss 11, p e3943 (2021)
institution DOAJ
collection DOAJ
language EN
topic Surgery
RD1-811
spellingShingle Surgery
RD1-811
Hannah Kornfeld, MD
Arianne Johnson, PhD
Marc Soares, MD, FACS
Katrina Mitchell, MD, FACS, IBCLC
Management of Infected Galactocele and Breast Implant with Uninterrupted Breastfeeding
description Summary:. Infected breast implants during lactation present a rare but challenging clinical scenario that may result in early cessation of breastfeeding and unnecessary morbidity to mother and infant. We present the case of a 39-year-old African American primigravid woman with a history of bilateral retropectoral textured implants placed three years prior. Five days after delivering a healthy, full-term infant via cesarean section, she sought evaluation for nipple pain and trauma. She was instructed to use a nipple shield and pump every 2–3 hours in addition to breastfeeding, which resulted in iatrogenic hyperlactation. One week postpartum, the patient was started on antibiotics for presumed mastitis. Ultrasound demonstrated a complex fluid collection at the 12 o’clock periareolar position, as well as peri-implant fluid. She subsequently underwent aspirations of a periareolar complex galactocele and aspirations of peri-implant fluid. She continued on antibiotics without improvement. The patient proceeded to implant removal and definitive drainage of the galactocele at four months postpartum. Throughout her course, the patient provided her infant with exclusive breastmilk, including breastfeeding in the perioperative area of the operating room. This case demonstrates an example of safe surgical removal of infected breast implants and management of an infected galactocele without interruption of breastfeeding.
format article
author Hannah Kornfeld, MD
Arianne Johnson, PhD
Marc Soares, MD, FACS
Katrina Mitchell, MD, FACS, IBCLC
author_facet Hannah Kornfeld, MD
Arianne Johnson, PhD
Marc Soares, MD, FACS
Katrina Mitchell, MD, FACS, IBCLC
author_sort Hannah Kornfeld, MD
title Management of Infected Galactocele and Breast Implant with Uninterrupted Breastfeeding
title_short Management of Infected Galactocele and Breast Implant with Uninterrupted Breastfeeding
title_full Management of Infected Galactocele and Breast Implant with Uninterrupted Breastfeeding
title_fullStr Management of Infected Galactocele and Breast Implant with Uninterrupted Breastfeeding
title_full_unstemmed Management of Infected Galactocele and Breast Implant with Uninterrupted Breastfeeding
title_sort management of infected galactocele and breast implant with uninterrupted breastfeeding
publisher Wolters Kluwer
publishDate 2021
url https://doaj.org/article/289e70e85be34f97b4f0f9f5979d1963
work_keys_str_mv AT hannahkornfeldmd managementofinfectedgalactoceleandbreastimplantwithuninterruptedbreastfeeding
AT ariannejohnsonphd managementofinfectedgalactoceleandbreastimplantwithuninterruptedbreastfeeding
AT marcsoaresmdfacs managementofinfectedgalactoceleandbreastimplantwithuninterruptedbreastfeeding
AT katrinamitchellmdfacsibclc managementofinfectedgalactoceleandbreastimplantwithuninterruptedbreastfeeding
_version_ 1718413547419992064